Shares of OR Royalties Inc. (NYSE:OR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $35.75.
A number of research firms have recently weighed in on OR. Zacks Research downgraded shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 19th. Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price on the stock in a research note on Thursday, November 6th. Canaccord Genuity Group raised OR Royalties from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 22nd. Jefferies Financial Group reissued a “hold” rating and issued a $38.00 price target on shares of OR Royalties in a research note on Sunday, December 7th. Finally, Scotiabank lowered shares of OR Royalties from an “outperform” rating to a “sector perform” rating and raised their price objective for the company from $33.00 to $41.00 in a research report on Thursday, October 23rd.
Read Our Latest Analysis on OR Royalties
Hedge Funds Weigh In On OR Royalties
OR Royalties Price Performance
NYSE OR opened at $38.57 on Wednesday. The firm has a market capitalization of $7.22 billion, a price-to-earnings ratio of 48.83 and a beta of 0.78. The company has a 50 day simple moving average of $34.56 and a 200-day simple moving average of $33.12. OR Royalties has a 52-week low of $17.55 and a 52-week high of $42.25.
OR Royalties (NYSE:OR – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.03. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. The firm had revenue of $71.63 million for the quarter, compared to analyst estimates of $53.85 million. On average, analysts predict that OR Royalties will post 0.62 EPS for the current year.
OR Royalties Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.055 per share. The ex-dividend date is Wednesday, December 31st. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.6%. OR Royalties’s dividend payout ratio (DPR) is currently 27.85%.
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Further Reading
- Five stocks we like better than OR Royalties
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Huge robotics rollout underway
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
